HFEA widens its criteria for preimplantation genetic diagnosisBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7551.1174 (Published 18 May 2006) Cite this as: BMJ 2006;332:1174
- Clare Dyer, legal correspondent
Screening embryos for a wider range of genetic conditions was given the go ahead by the Human Fertilisation and Embryology Authority (HFEA), the United Kingdom's fertility watchdog, last week.
Preimplantation genetic diagnosis was already approved for a limited number of conditions with which a baby is born—such as cystic fibrosis—or that it risks developing early in life—for example, the cancers retinoblastoma and familial adenomatous polyposis. Both cancers have “high penetrance”—children born with the genetic mutation have a 90% chance of developing the condition.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial